Assessing the Validity and Reliability of the Effects of Youngsters' Eyesight on Quality of Life Questionnaire Among Children With Uveitis.
Journal
Arthritis care & research
ISSN: 2151-4658
Titre abrégé: Arthritis Care Res (Hoboken)
Pays: United States
ID NLM: 101518086
Informations de publication
Date de publication:
03 2022
03 2022
Historique:
revised:
05
10
2020
received:
01
05
2020
accepted:
15
10
2020
pubmed:
22
10
2020
medline:
11
3
2022
entrez:
21
10
2020
Statut:
ppublish
Résumé
The Effects of Youngsters' Eyesight on Quality of Life (EYE-Q) questionnaire measures vision-related functioning (VRF) and vision-related quality of life (VRQoL) in children with uveitis. Our aim was to revise the alpha version of the EYE-Q to refine VRF and VRQoL subscales and to assess the validity of the EYE-Q. Children with juvenile idiopathic arthritis (JIA), JIA-associated uveitis, and other noninfectious uveitis were enrolled. Patients and parents completed the EYE-Q, Pediatric Quality of Life Inventory (overall quality of life), and Childhood Health Assessment Questionnaire (physical functioning). The development site completed the alpha version of the EYE-Q, and the composite sites completed the beta version. We compared item-subscale correlations, internal consistency, and construct and discriminant validity among the different versions. Of the 644 patients enrolled, 61.6% completed the alpha version, and 38.4% the beta version of the EYE-Q. Mean ± SD patient age was 11.1 ± 4.2 years, and 70% were female. Fewer White patients (73.5%) completed the alpha version compared to the beta version (86.2%; P < 0.001). With the exception of patient-reported VRF, both versions had similar item-subscale correlations. Version comparisons on scale internal consistencies indicated significant differences for parent- and patient-reported VRF, but each scale had a Cronbach's α of >0.80 beta. When data were combined, the EYE-Q showed significant differences between JIA-only and uveitis patients on all parent and patient scores, except for patient-reported VRF. The EYE-Q appears to be a valid measure of VRF and VRQoL in pediatric uveitis. Our results suggest it may be used as an outcome measure in multicenter pediatric uveitis studies.
Types de publication
Journal Article
Multicenter Study
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't
Validation Study
Langues
eng
Sous-ensembles de citation
IM
Pagination
355-363Subventions
Organisme : NIAMS NIH HHS
ID : P30 AR076316
Pays : United States
Organisme : NEI NIH HHS
ID : L40 EY019856
Pays : United States
Organisme : NEI NIH HHS
ID : K23 EY021760
Pays : United States
Informations de copyright
© 2020 American College of Rheumatology.
Références
Thorne JE, Woreta F, Kedhar SR, Dunn JP, Jabs DA. Juvenile idiopathic arthritis-associated uveitis: incidence of ocular complications and visual acuity loss. Am J Ophthalmol 2007;143:840-6.
Ravelli A, Martini A. Juvenile idiopathic arthritis. Lancet 2007;369:767-78.
Cassidy JT, Petty RE, Laxer RM, Lindsley CB. Textbook of pediatric rheumatology. Philadelphia: Elsevier Saunders; 2005.
Kump LI, Cervantes-Castaneda RA, Androudi SN, Foster CS. Analysis of pediatric uveitis cases at a tertiary referral center. Ophthalmology 2005;112:1287-92.
Kanski JJ, Shun-Shin GA. Systemic uveitis syndromes in childhood: an analysis of 340 cases. Ophthalmology 1984;91:1247-52.
Maca SM, Amirian A, Prause C, Gruber K, Mejdoubi L, Barisani-Asenbauer T. Understanding the impact of uveitis on health-related quality of life in adolescents. Acta Ophthalmol 2013;91:e219-24.
Solebo AL, Barry RJ, Keane PA, Rahi JS, Denniston AK. Under-utilisation of reproducible, child appropriate or patient reported outcome measures in childhood uveitis interventional research. Orphanet J Rare Dis 2019;14:125.
Ezzahri M, Amine B, Rostom S, Rifay Y, Badri D, Mawani N, et al. The uveitis and its relationship with disease activity and quality of life in Moroccan children with juvenile idiopathic arthritis. Clin Rheumatol 2013;32:1387-91.
Sestan M, Grguric D, Sedmak M, Frkovic M, Kifer N, Grubic M, et al. Quality of life in children suffering from juvenile idiopathic arthritis-associated uveitis. Rheumatol Int 2020;40:1117-21.
Taha R, Papadopoulou M, Zetterberg M, Oskarsdottir S, Gronlund MA. Visual function and quality of life in a cohort of Swedish children with juvenile idiopathic arthritis. Clin Ophthalmol 2019;13:2081-91.
World Health Organization Quality of Life Group. The development of the World Health Organization Quality of Life assessment instrument (the WHOQOL). Berlin: Springer-Verlag; 1994.
Frick KD, Drye LT, Kempen JH, Dunn JP, Holland GN, Latkany P, et al. Associations among visual acuity and vision- and health-related quality of life among patients in the Multicenter Uveitis Steroid Treatment trial. Invest Ophthalmol Vis Sci 2012;53:1169-76.
Moorthy LN, Peterson MG, Harrison MJ, Onel KB, Lehman TJ. Physical function assessment tools in pediatric rheumatology. Pediatr Rheumatol Online J 2008;6:9.
Gutierrez-Suarez R, Pistorio A, Cespedes Cruz A, Norambuena X, Flato B, Rumba I, et al. Health-related quality of life of patients with juvenile idiopathic arthritis coming from 3 different geographic areas: the PRINTO Multinational Quality of Life cohort study. Rheumatology (Oxford) 2007;46:314-20.
Angeles-Han ST. Quality-of-life metrics in pediatric uveitis. Int Ophthalmol Clin 2015;55:93-101.
Parker DM, Angeles-Han ST, Stanton AL, Holland GN. Chronic anterior uveitis in children: psychosocial challenges for patients and their families. Am J Ophthalmol 2018;191:vxi-xxiv.
Haasnoot AJ, Sint Jago NF, Tekstra J, de Boer JH. Impact of uveitis on quality of life in adult patients with juvenile idiopathic arthritis. Arthritis Care Res (Hoboken) 2017;69:1895-902.
Mangione CM, Lee PP, Gutierrez PR, Spritzer K, Berry S, Hays RD. Development of the 25-item National Eye Institute Visual Function Questionnaire. Arch Ophthalmol 2001;119:1050-8.
Bertrand PJ, Jamilloux Y, Kodjikian L, Errera MH, Perard L, Pugnet G, et al. Quality of life in patients with uveitis: data from the ULISSE study (Uveitis: cLInical and medico-economic evaluation of a Standardised Strategy for the Etiological diagnosis). Br J Ophthalmol 2021;105:935-40.
Sugar EA, Burke AE, Venugopal V, Thorne JE, Holbrook JT, Multicenter Uveitis Steroid Treatment Trial and Follow-up Study Research Group. Responsiveness of vision-specific and general quality of life metrics to ocular and systemic events in patients with uveitis. Ophthalmology 2020;127:1710-8.
Leske DA, Hatt SR, Castaneda YS, Wernimont SM, Liebermann L, Cheng-Patel CS, et al. Validation of the Pediatric Eye Questionnaire in children with visual impairment. Am J Ophthalmol 2019;208:124-32.
Tadic V, Robertson AO, Cortina-Borja M, Rahi JS, Child Vision Patient-Reported Outcome Measures Group. An age- and stage-appropriate patient-reported outcome measure of vision-related quality of life of children and young people with visual impairment. Ophthalmology 2020;127:249-60.
Birch EE, Cheng CS, Felius J. Validity and reliability of the Children's Visual Function Questionnaire (CVFQ). J AAPOS 2007;11:473-9.
Gothwal VK, Lovie-Kitchin JE, Nutheti R. The development of the LV Prasad-Functional Vision Questionnaire: a measure of functional vision performance of visually impaired children. Invest Ophthalmol Vis Sci 2003;44:4131-9.
Khadka J, Ryan B, Margrain TH, Court H, Woodhouse JM. Development of the 25-item Cardiff Visual Ability Questionnaire for Children (CVAQC). Br J Ophthalmol 2010;94:730-5.
Cochrane GM, Marella M, Keeffe JE, Lamoureux EL. The impact of vision impairment for children (IVI_C): validation of a vision-specific pediatric quality-of-life questionnaire using Rasch analysis. Invest Ophthalmol Vis Sci 2011;52:1632-40.
Angeles-Han ST, Griffin KW, Lehman TJ, Rutledge JR, Lyman S, Nguyen JT, et al. The importance of visual function in the quality of life of children with uveitis. J AAPOS 2010;14:163-8.
Angeles-Han ST, Griffin KW, Harrison MJ, Lehman TJ, Leong T, Robb RR, et al. Development of a vision-related quality of life instrument for children ages 8-18 years for use in juvenile idiopathic arthritis-associated uveitis. Arthritis Care Res (Hoboken) 2011;63:1254-61.
Angeles-Han ST, Yeh S, McCracken C, Jenkins K, Stryker D, Myoung E, et al. Using the effects of youngsters' eyesight on quality of life questionnaire to measure visual outcomes in children with uveitis. Arthritis Care Res (Hoboken) 2015;67:1513-20.
Petty RE, Southwood TR, Manners P, Baum J, Glass DN, Goldenberg J, et al. International League of Associations for Rheumatology classification of juvenile idiopathic arthritis: second revision, Edmonton, 2001. J Rheumatol 2004;31:390-2.
Varni JW, Seid M, Kurtin PS. PedsQL 4.0: reliability and validity of the Pediatric Quality of Life Inventory version 4.0 generic core scales in healthy and patient populations. Med Care 2001;39:800-12.
Singh G, Athreya BH, Fries JF, Goldsmith DP. Measurement of health status in children with juvenile rheumatoid arthritis. Arthritis Rheum 1994;37:1761-9.
Nunnally JC. Psychometric theory. New York: McGraw-Hill; 1978.
Tavakol M, Dennick R. Making sense of Cronbach's alpha. Int J Med Educ 2011;2:53-5.
McLeod S. What does effect size tell you? 2019. URL: https://www.simplypsychology.org/effect-size.html.
Wallander JL, Fradkin C, Elliott MN, Cuccaro PM, Tortolero Emery S, Schuster MA. Racial/ethnic disparities in health-related quality of life and health status across pre-, early-, and mid-adolescence: a prospective cohort study. Qual Life Res 2019;28:1761-71.
Angeles-Han ST, McCracken C, Yeh S, Jenkins K, Stryker D, Travers C, et al. The association of race with childhood uveitis. Am J Ophthalmol 2015;160:919-28.
Foeldvari I, Klotsche J, Simonini G, Edelsten C, Angeles-Han ST, Bangsgaard R, et al. Proposal for a definition for response to treatment, inactive disease and damage for JIA associated uveitis based on the validation of a uveitis related JIA outcome measures from the Multinational Interdisciplinary Working Group for Uveitis in Childhood (MIWGUC). Pediatr Rheumatol Online J 2019;17:66.
Heiligenhaus A, Foeldvari I, Edelsten C, Smith JR, Saurenmann RK, Bodaghi B, et al. Proposed outcome measures for prospective clinical trials in juvenile idiopathic arthritis-associated uveitis: a consensus effort from the Multinational Interdisciplinary Working Group for Uveitis in Childhood. Arthritis Care Res (Hoboken) 2012;64:1365-72.
Jabs DA, Nussenblatt RB, Rosenbaum JT. Standardization of uveitis nomenclature for reporting clinical data: results of the first international workshop. Am J Ophthalmol 2005;140:509-16.
Lovell DJ, Brunner HI, Ringold S, Weiss PF, Martin N, Consolaro A, et al. The American English version of the Juvenile Arthritis Multidimensional Assessment Report (JAMAR). Rheumatol Int 2018;38 Suppl 1:35-42.
Drotar D. Measuring health-related quality of life in children and adolescents: implications for research and practice. Mahwah (NJ): Lawrence Erlbaum; 1998.